Cargando…
Combined therapy with methotrexate nanoconjugate and dendritic cells with downregulated IL-10R expression modulates the tumor microenvironment and enhances the systemic anti-tumor immune response in MC38 murine colon carcinoma
BACKGROUND: Understanding the negative impact of the tumor microenvironment on the creation of an effective immune response has contributed to the development of new therapeutic anti-cancer strategies. One such solution is combined therapy consisting of chemotherapeutic administration followed by de...
Autores principales: | Szczygieł, Agnieszka, Węgierek-Ciura, Katarzyna, Wróblewska, Anna, Mierzejewska, Jagoda, Rossowska, Joanna, Szermer-Olearnik, Bożena, Świtalska, Marta, Anger-Góra, Natalia, Goszczyński, Tomasz M., Pajtasz-Piasecka, Elżbieta |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10078943/ https://www.ncbi.nlm.nih.gov/pubmed/37033926 http://dx.doi.org/10.3389/fimmu.2023.1155377 |
Ejemplares similares
-
Inhibition of MC38 colon cancer growth by multicomponent chemoimmunotherapy with anti-IL-10R antibodies, HES-MTX nanoconjugate, depends on application of IL-12, IL-15 or IL-18 secreting dendritic cell vaccines
por: Węgierek-Ciura, Katarzyna, et al.
Publicado: (2023) -
Immunomodulatory potential of anticancer therapy composed of methotrexate nanoconjugate and dendritic cell-based vaccines in murine colon carcinoma
por: Szczygieł, Agnieszka, et al.
Publicado: (2021) -
The Beneficial Effect of IL-12 and IL-18 Transduced Dendritic Cells Stimulated with Tumor Antigens on Generation of an Antitumor Response in a Mouse Colon Carcinoma Model
por: Mierzejewska, Jagoda, et al.
Publicado: (2022) -
Antitumor Potential of Extracellular Vesicles Released by Genetically Modified Murine Colon Carcinoma Cells With Overexpression of Interleukin-12 and shRNA for TGF-β1
por: Rossowska, Joanna, et al.
Publicado: (2019) -
Treatment with lentiviral vectors encoding shRNA against interleukin 10 modulates the immunosuppressive activity of murine colon carcinoma-associated myeloid-derived suppressor cells
por: Anger-Góra, Natalia, et al.
Publicado: (2021)